GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » EV-to-Revenue

PT Pyridam Farma Tbk (ISX:PYFA) EV-to-Revenue : 3.16 (As of Jun. 01, 2025)


View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PT Pyridam Farma Tbk's enterprise value is Rp6,075,449 Mil. PT Pyridam Farma Tbk's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was Rp1,920,812 Mil. Therefore, PT Pyridam Farma Tbk's EV-to-Revenue for today is 3.16.

The historical rank and industry rank for PT Pyridam Farma Tbk's EV-to-Revenue or its related term are showing as below:

ISX:PYFA' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.39   Med: 1.07   Max: 7.33
Current: 3.16

During the past 13 years, the highest EV-to-Revenue of PT Pyridam Farma Tbk was 7.33. The lowest was 0.39. And the median was 1.07.

ISX:PYFA's EV-to-Revenue is ranked worse than
60.02% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs ISX:PYFA: 3.16

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), PT Pyridam Farma Tbk's stock price is Rp228.00. PT Pyridam Farma Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was Rp215.04. Therefore, PT Pyridam Farma Tbk's PS Ratio for today is 1.06.


PT Pyridam Farma Tbk EV-to-Revenue Historical Data

The historical data trend for PT Pyridam Farma Tbk's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Pyridam Farma Tbk EV-to-Revenue Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 1.50 1.73 2.15 3.06

PT Pyridam Farma Tbk Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 2.01 5.77 4.68 3.06

Competitive Comparison of PT Pyridam Farma Tbk's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Pyridam Farma Tbk's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's EV-to-Revenue falls into.


;
;

PT Pyridam Farma Tbk EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PT Pyridam Farma Tbk's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6075448.834/1920811.833
=3.16

PT Pyridam Farma Tbk's current Enterprise Value is Rp6,075,449 Mil.
PT Pyridam Farma Tbk's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1,920,812 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Pyridam Farma Tbk  (ISX:PYFA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PT Pyridam Farma Tbk's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=228.00/215.036
=1.06

PT Pyridam Farma Tbk's share price for today is Rp228.00.
PT Pyridam Farma Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp215.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Pyridam Farma Tbk EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Pyridam Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower Lt. 12, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines